03467nam 2201093z- 450 991056645820332120231214133153.0(CKB)5680000000037799(oapen)https://directory.doabooks.org/handle/20.500.12854/80955(EXLCZ)99568000000003779920202205d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierBiomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases ManagementBaselMDPI - Multidisciplinary Digital Publishing Institute20221 electronic resource (208 p.)3-0365-3746-5 3-0365-3745-7 This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.MedicinebicsscpharmacogenomicsNGS variantspersonalized medicineFSHRpersonalized drug therapyhedgehog-interacting proteinimpaired fasting glucoseimpaired glucose tolerancenewly diagnosed diabetesnormal glucose toleranceinflammatory bowel diseaseulcerative colitisCrohn’s diseaseextracellular matrix componentshyaluronaninflammatory bowel diseases (IBD)Crohn’s disease (CD)ulcerative colitis (UC)sulfated glycosaminoglycans (sGAG)hyaluronan (HA)soluble part of syndecan-1 (sCD138)microRNAcardiovascular diseasediabetesmortalityantiplatelet therapyplatelet reactivityLet-7emiR-126miR-223miR-125a-3pCCL11CCL24CCL26CCR3CRCadiponectinadipokinesrheumatologyobesityoverweightcase control studyrheumatoid arthritisTNF-α inhibitorsbone turnover markersPINPPICPNTX-ICTX-IRANKL/OPGovarian cancerinterleukin 21interleukin 22lymphocytesmacrophagesdendritic cellsinnate lymphoid cellsbreast cancerextracellular matrixproteinstumorigenesistumor microenvironmentMedicineKomosinska-Vassev Katarzynaedt1319548Olczyk PaweledtKomosinska-Vassev KatarzynaothOlczyk PawelothBOOK9910566458203321Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management3033952UNINA